Skip to main content
Top
Published in: Pathology & Oncology Research 1/2016

01-01-2016 | Original Article

Clinicopathological Variation of Lauren Classification in Gastric Cancer

Published in: Pathology & Oncology Research | Issue 1/2016

Login to get access

Abstract

The investigation of prognostic factor for gastric cancer is still desirable because of dismal prognosis in gastric cancer. Lauren’s classification is currently a useful histological classification. There are few large series evaluating the prognostic significance of Lauren’s classification in gastric cancer. From January 1987 to December 2013, a total of 3071 patients received gastrectomy for gastric cancer. According Lauren’s classification, 1423(46.3 %) patients were intestinal type, 1000 patients (32.6 %) were diffuse type, and 648 patients (21.1 %) were mixed type. The clinicopathological characteristics and prognosis in Lauren’s classification were analyzed in these patients. Our results showed that patients with intestinal type gastric cancer (57.7 %) had a better 5-year overall survival than diffuse type (45.6 %) and mixed type (43.4 %, P < 0.001). The clinicopathological characteristics showed that gastric cancer patients with intestinal type were older (P < 0.001), male predominant (P < 0.001), smaller tumor size (P < 0.001), distal stomach predominant (P < 0.001), relative well differentiated (P < 0.001), less advanced Borrmann type (P < 0.001), less scirrhous type stromal reaction(P < 0.001), less infiltrating type of Ming’s histology type(P < 0.001), less tumor invasion depth and less lymphovascular invasion (P < 0.001). Multivariate analysis with overall survival as an endpoint showed that age (P = 0.005), Borrmann classification (P < 0.001), pathological T category (P = 0.023), pathological N category (P < 0.001) and Lauren’s classification (P = 0.003) were significant correlated in gastric cancer. Lauren’s classification is an independent prognostic factor in gastric cancer patient undergoing gastrectomy. Lauren’s classification can serve as a prognostic marker for gastric cancer patient receiving gastrectomy. The clinicopathological appearance and prognosis of mixed type gastric cancer is similar to diffuse type gastric cancer.
Literature
1.
go back to reference Taiwan Public Health Report 2012, Department of Health, Executive Yuan, R.O.C. (Taiwan) Taiwan Public Health Report 2012, Department of Health, Executive Yuan, R.O.C. (Taiwan)
2.
go back to reference Wu CW, Hsiung CA, Lo SS et al (2006) Nodal dissection for patients with gastric cancer: a randomized controlled trial. Lancet Oncol 7:309–315CrossRefPubMed Wu CW, Hsiung CA, Lo SS et al (2006) Nodal dissection for patients with gastric cancer: a randomized controlled trial. Lancet Oncol 7:309–315CrossRefPubMed
3.
go back to reference Hartgrink HH, van de Velde CJH, Putter H et al (2004) Extended lymph-node dissection for gastric cancer: who may benefit? final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22:2069–2077CrossRefPubMed Hartgrink HH, van de Velde CJH, Putter H et al (2004) Extended lymph-node dissection for gastric cancer: who may benefit? final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22:2069–2077CrossRefPubMed
4.
go back to reference Lauren P (1965) The two histologic main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma, an attempt at a histo-clinicalclassification. Acta Parhol Microb Scan 64:31–49 Lauren P (1965) The two histologic main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma, an attempt at a histo-clinicalclassification. Acta Parhol Microb Scan 64:31–49
5.
go back to reference Qiu MZ, Cai MY, Zhang DS et al (2013) Clinicopathological characteristics and prognostic analysis of lauren classification in gastric adenocarcinoma in China. J Transl Med 11:58PubMedCentralCrossRefPubMed Qiu MZ, Cai MY, Zhang DS et al (2013) Clinicopathological characteristics and prognostic analysis of lauren classification in gastric adenocarcinoma in China. J Transl Med 11:58PubMedCentralCrossRefPubMed
6.
go back to reference Berlth F, Bollschweiler E, Drebber U et al (2014) Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value. World J Gastroenterol 20(19):5679–5684PubMedCentralCrossRefPubMed Berlth F, Bollschweiler E, Drebber U et al (2014) Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value. World J Gastroenterol 20(19):5679–5684PubMedCentralCrossRefPubMed
8.
go back to reference American Joint Committee on Cancer (2010) AJCC cancer staging manual, 7th edn. Springer, New YorkCrossRef American Joint Committee on Cancer (2010) AJCC cancer staging manual, 7th edn. Springer, New YorkCrossRef
9.
go back to reference Komatsu S, Ichikawa D, Miyamae M et al (2015) Histological mixed-type as an independent prognostic factor in stage I gastric carcinoma. World J Gastroenterol 21(2):549–555PubMedCentralCrossRefPubMed Komatsu S, Ichikawa D, Miyamae M et al (2015) Histological mixed-type as an independent prognostic factor in stage I gastric carcinoma. World J Gastroenterol 21(2):549–555PubMedCentralCrossRefPubMed
10.
go back to reference Zheng HC, Li XH, Hara T et al (2008) Mixed type gastric carcinoma exhibit more aggressive features and indicate the histogenesis of carcinomas. Virchows Arch 452(5):525–534PubMedCentralCrossRefPubMed Zheng HC, Li XH, Hara T et al (2008) Mixed type gastric carcinoma exhibit more aggressive features and indicate the histogenesis of carcinomas. Virchows Arch 452(5):525–534PubMedCentralCrossRefPubMed
11.
go back to reference Gravalos C, Jimeno A (2008) HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol 19(9):1523–1529CrossRefPubMed Gravalos C, Jimeno A (2008) HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol 19(9):1523–1529CrossRefPubMed
12.
go back to reference Qiu M, Zhou Y, Zhong X et al (2014) Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients. BMC Cancer 14:823PubMedCentralCrossRefPubMed Qiu M, Zhou Y, Zhong X et al (2014) Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients. BMC Cancer 14:823PubMedCentralCrossRefPubMed
Metadata
Title
Clinicopathological Variation of Lauren Classification in Gastric Cancer
Publication date
01-01-2016
Published in
Pathology & Oncology Research / Issue 1/2016
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-015-9996-6

Other articles of this Issue 1/2016

Pathology & Oncology Research 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine